Results 231 to 240 of about 9,604,877 (389)

The emerging safety profile of JAK inhibitors in rheumatic disease

Nature Reviews Rheumatology, 2017
K. Winthrop
semanticscholar   +1 more source

Real-world trends in rheumatic disease rates among pregnancies in Ontario, Canada: A repeated cross-sectional study. [PDF]

PLoS One
Tharmarajah S, Abideen Z, Hussain S, Guilcher SJT, McCarthy LM, Mahendira D, Berger H, Tadrous M.   +7 more
europepmc   +1 more source

Controlled Release of Human Dental Pulp Stem Cell‐Derived Exosomes from Hydrogels Attenuates Temporomandibular Joint Osteoarthritis

Advanced Healthcare Materials, EarlyView.
Exosomes can reduce tissue damage in temporomandibular joint osteoarthritis (TMJOA), but rapid clearance limits their efficacy. This study encapsulates exosomes in hyaluronic acid hydrogels for controlled release. In a rat model, hydrogel‐encapsulated exosomes outperform free exosomes in preserving bone integrity and reducing tissue destruction ...
Victor Diez‐Guardia, Yajing Tian, Yunzhe Guo, Jiaying Li, Shengjie Cui, Cécile A. Dreiss, Eileen Gentleman, Xuedong Wang   +7 more
wiley   +1 more source

Safety and Effectiveness of Combination Rituximab and Cyclophosphamide Therapy for Treating Pediatric Patients With Severe Manifestations of Rheumatic Disease. [PDF]

ACR Open Rheumatol
Rife E, Reiff D, Bridges J, Cron RQ, Smitherman E, Stoll ML, Timmerman L, Weiser P, Mannion ML.   +8 more
europepmc   +1 more source

Medical Disorders of the Locomotor System Including the Rheumatic Diseases.Ernest Fletcher

, 1950
Nephi K. Kezerian
openalex   +1 more source

Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis

Advanced Healthcare Materials, EarlyView.
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han, Weiping Lin, Yuanxiong Cao, Patricia Murray, Bettina Wilm, Stephen J McWilliam, Jude Curran, Ruoxiao Xie   +7 more
wiley   +1 more source

Clinical, radiologic, and serologic predictors of rheumatic disease in interstitial lung disease patients. [PDF]

Clin Rheumatol
Bozkurt T, Dincses-Nas E, Batibay S, Tekin ZN, Kasapoglu E.   +4 more
europepmc   +1 more source

Rheumatic Heart Disease [PDF]

, 1962
B M Ansell
openalex   +1 more source

Pulmonary Delivery of siRNA Anti‐TNFα‐loaded Lipid Nanoparticles for Rapid Recovery in Murine Acute Lung Injury

Advanced Healthcare Materials, EarlyView.
In a murine model of acute lung injury, pulmonary administration of lipid nanoparticles carrying TNFα siRNA enables targeted delivery to immune cells. The study emphasises the importance of optimizing LNP distribution and delivery timing to improve therapeutic outcomes and develop emergency therapies for lung hyperinflammation.
Qinglin Wang, Jihana Achour, Laila Emam, Younes Louaguenouni, Catherine Cailleau, Françoise Mercier‐Nomé, Séverine Domenichini, Claudine Delomenie, Sezen Gul, Juliette Vergnaud, Nicolas Tsapis, Arnaud Mansart, Djillali Annane, Francois Fay, Elias Fattal   +14 more
wiley   +1 more source

Thoracic manifestations of rheumatic disease: a radiologist's view. [PDF]

Ther Adv Musculoskelet Dis
De Clercq A, Jans L, Gosselin R, Delrue L, Vereecke E, Parkar AP, Schiettecatte E, Lecluyse C, Smeets P, Herregods N, Morbée L.   +10 more
europepmc   +1 more source